AI-powered platform that analyzes retinal images to identify early signs of eye diseases and assess cardiovascular disease risk. The system provides standardized risk assessment reporting to support clinical decision-making and reduce missed diagnoses.
Manufactured by
Optain Health
Australia
Optain's AI-enabled Software as a Medical Device (SaMD) and Portable Automatic Fundus Camera Turnkey Solution have been designed and developed as an all-in-one, ready-to-use package. This combination allows clinicians to quickly capture and analyse high-quality retinal images for early signs of eye disease.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Mediwhale Inc.
South Korea · 2 relevant products
CHECK-EYE
Germany · 2 relevant products
Aireen a.s.
Czech Republic · 5 relevant products
17 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 31 closest product alternatives
Mediwhale Inc. · South Korea
Deep learning-based platform that processes retinal images to assess cardiovascular, kidney, and eye disease risks. Trained on over 2.1 million clinical data points across diverse populations and imaging devices for robust, generalizable diagnostic performance.
CHECK-EYE · Germany
AI-powered platform for early detection of retinal changes and diabetic retinopathy. Analyzes fundus photographs to identify pathological changes at early stages before symptom onset. Results are generated within minutes and reviewed by medical professionals.
CHECK-EYE · Germany
AI-powered platform for early detection of retinal changes and chronic eye disease via fundus imaging analysis. Enables rapid, non-invasive screening for diabetic retinopathy and other retinal pathology by analyzing fundus photographs. Supports preventive ophthalmology and patient risk stratification in primary care and community settings.
28 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products